Robbie Stephens Cuts Affymetrix Rating

Analyst Michael King thinks the shares will be dead money until a chip- and instrument-market recovery later this year

Robertson Stephens downgraded Affymetrix (AFFX ) to market perform from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.